Send to

Choose Destination
Am J Kidney Dis. 2018 Jan;71(1):65-74. doi: 10.1053/j.ajkd.2017.07.015. Epub 2017 Nov 20.

Insulin Sensitivity and Diabetic Kidney Disease in Children and Adolescents With Type 2 Diabetes: An Observational Analysis of Data From the TODAY Clinical Trial.

Collaborators (199)

McKay S, Haymond M, Anderson B, Bush C, Gunn S, Holden H, Jones SM, Jeha G, McGirk S, Thamotharan S, Cuttler L, Abrams E, Casey T, Dahms W, Ievers-Landis C, Kaminski B, Koontz M, MacLeish S, McGuigan P, Narasimhan S, Geffner M, Barraza V, Chang N, Conrad B, Dreimane D, Estrada S, Fisher L, Fleury-Milfort E, Hernandez S, Hollen B, Kaufman F, Law E, Mansilla V, Miller D, Muñoz C, Ortiz R, Ward A, Wexler K, Xu YK, Yasuda P, Levitt Katz L, Berkowitz R, Boyd S, Johnson B, Kaplan J, Keating C, Lassiter C, Lipman T, McGinley G, McKnight H, Schwartzman B, Willi S, Arslanian S, Bacha F, Foster S, Galvin B, Hannon T, Kriska A, Libman I, Marcus M, Porter K, Songer T, Venditti E, Goland R, Gallagher D, Kringas P, Leibel N, Ng D, Ovalles M, Seidman D, Laffel L, Goebel-Fabbri A, Hall M, Higgins L, Keady J, Malloy M, Milaszewski K, Rasbach L, Nathan DM, Angelescu A, Bissett L, Ciccarelli C, Delahanty L, Goldman V, Hardy O, Larkin M, Levitsky L, McEachern R, Norman D, Nwosu D, Park-Bennett S, Richards D, Sherry N, Steiner B, Tollefsen S, Carnes S, Dempsher D, Flomo D, Whelan T, Wolff B, Weinstock R, Bowerman D, Bristol S, Bulger J, Hartsig J, Izquierdo R, Kearns J, Saletsky R, Trief P, Zeitler P, Abramson N, Bradhurst A, Celona-Jacobs N, Higgins J, Kelsey M, Klingensmith G, Nadeau K, Witten T, Copeland K, Boss E, Brown R, Chadwick J, Chalmers L, Chernausek S, Hebensperger A, Macha C, Newgent R, Nordyke A, Olson D, Poulsen T, Pratt L, Preske J, Schanuel J, Sternlof S, Lynch J, Amodei N, Barajas R, Cody C, Hale D, Hernandez J, Ibarra C, Morales E, Rivera S, Rupert G, Wauters A, White N, Arbeláez A, Flomo D, Jones J, Jones T, Sadler M, Tanner M, Timpson A, Welch R, Caprio S, Grey M, Guandalini C, Lavietes S, Rose P, Syme A, Tamborlane W, Hirst K, Edelstein S, Feit P, Grover N, Long C, Pyle L, Linder B, Marcovina SM, Harting J, Shepherd J, Fan B, Marquez L, Sherman M, Wang J, Nichols M, Mayer-Davis E, Liu Y, Lima J, Gidding S, Puccella J, Ricketts E, Danis R, Domalpally A, Goulding A, Neill S, Vargo P, Wilfley D, Aldrich-Rasche D, Franklin K, Massmann C, O'Brien D, Patterson J, Tibbs T, Van Buren D, Palmert M, Ratner R, Dremaine D, Silverstein J.

Author information

University of Colorado Anschutz Medical Campus and Children's Hospital Colorado, Aurora, CO.
Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
George Washington University Biostatistics Center, Rockville, MD. Electronic address:
Texas Children's Hospital, Baylor College of Medicine, Houston, TX.
Children's Hospital University of Pittsburgh Medical Center, Pittsburgh, PA.
Baylor College of Medicine, Houston, TX.
Children's Hospital of Philadelphia, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.
Joslin Diabetes Center, Boston, MA.



Diabetic kidney disease is a major cause of premature mortality in type 2 diabetes mellitus (T2DM). Worsening insulin sensitivity independent of glycemic control may contribute to the development of diabetic kidney disease. We investigated the longitudinal association of insulin sensitivity with hyperfiltration and increased albumin excretion in adolescents with T2DM.


Observational prospective cohort study.


532 TODAY (Treatment Options for Type 2 Diabetes in Adolescents and Youth) participants aged 12 to 17 years with T2DM duration less than 2 years at baseline. The TODAY Study was a multicenter randomized clinical trial that examined the efficacy of 3 treatment regimens (metformin monotherapy, metformin plus rosiglitazone, or metformin plus an intensive lifestyle intervention program) to achieve durable glycemic control.


Natural log-transformed estimated insulin sensitivity (reciprocal of fasting insulin), hemoglobin A1c concentration, age, race-ethnicity, treatment group, body mass index, loss of glycemic control, and hypertension.


Hyperfiltration was defined as 99th percentile or higher of estimated glomerular filtration rate (≥140mL/min/1.73m2) when referenced to healthy adolescents (NHANES 1999-2002) and albumin-creatinine ratio ≥ 30μg/mg at 3 consecutive annual visits.


Hyperfiltration was observed in 7.0% of participants at baseline and in 13.3% by 5 years, with a cumulative incidence of 5.0% over 5 years. The prevalence of increased albumin excretion was 6% at baseline and 18% by 5 years, with a cumulative incidence of 13.4%. There was an 8% increase in risk for hyperfiltration per 10% lower estimated insulin sensitivity in unadjusted and adjusted models (P=0.01). Increased albumin excretion was associated with hemoglobin A1c concentration, but not estimated insulin sensitivity.


Longer follow-up is needed to capture the transition from hyperfiltration to rapid glomerular filtration rate decline in youth-onset T2DM.


Lower estimated insulin sensitivity was associated with risk for hyperfiltration over time, whereas increased albumin excretion was associated with hyperglycemia in youth-onset T2DM.


Type 2 diabetes mellitus (T2DM); adolescents; albumin-creatinine ratio (ACR); children; creatinine; cystatin C; diabetic kidney disease (DKD); disease progression; estimated glomerular filtration rate (eGFR); hyperfiltration; increased albumin excretion; insulin sensitivity; kidney function; youth-onset T2DM

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center